Pharmacy Report Archives - Page 109 of 136 - Becker's Hospital Review

Moderna delays COVID-19 vaccine trial | NIH director: Coronavirus mutations won't complicate vaccination strategy | 10 advancements in healthcare tech | Glenmark charged in $200M price-fixing scheme

July 6, 2020 BHR Newsletter Virtual Events • Webinars • Recent Whitepapers • Podcasts 1. Moderna delays COVID-19 vaccine trial Full story 2. Glenmark Pharmaceuticals charged in alleged $200M price-fixing scheme Full story 3. Early use of hydroxychloroquine reduced COVID-19 deaths, study says Full story…

Fla. runs out of remdesivir | Novartis to pay $678M to settle kickback suit | Idaho pharmacy joins Kootenai Health | PhRMA sues to block Minn. insulin law | 6 drug approvals + 10 hospitals hiring pharma leaders

July 2, 2020 BHR Newsletter Virtual Events • Webinars • Recent Whitepapers • Podcasts 1. Novartis to pay $678M to settle kickback lawsuit Full story 2. Independent Idaho pharmacy joins Kootenai Health Full story 3. South Florida hospitals halt elective surgeries; state runs out…

Labs: Expect test result delays | Pfizer reports positive COVID-19 vaccine data | Walgreens testing smaller stores | FDA sets COVID-19 vaccine guidance: 4 notes | Ex-Indivior CEO pleads guilty in federal opioid case

July 1, 2020 BHR Newsletter Virtual Events • Webinars • Recent Whitepapers • Podcasts 1. Walgreens testing smaller store format: 8 things to know Full story 2. Labs warn of test result delays amid coronavirus surges Full story 3. FDA releases guidance on COVID-19…

CVS reportedly starting GPO | IBM Watson's top 100 hospitals | HHS secures 500K courses of remdesivir for hospitals | 245 drugs saw price hikes in 6 months | Novartis to pay $347M to resolve kickback charges

June 30, 2020 BHR Newsletter Virtual Events • Webinars • Recent Whitepapers • Podcasts 1. CVS Health reportedly launching a GPO called Zinc Full story 2. HHS secures 500,000 courses of remdesivir for US hospitals Full story 3. Prices of 245 drugs hiked in…

Gilead sets remdesivir price, allocation plan | 2 patients die in Audentes gene therapy study | Pfizer sues HHS | US warns 2nd COVID-19 wave may worsen drug shortages | Pharma giants to unveil $1B antibiotic venture

June 29, 2020 BHR Newsletter Virtual Events • Webinars • Recent Whitepapers • Podcasts 1. Gilead sets remdesivir price, allocation plan Full story 2. Pfizer sues HHS over Medicare rules Full story 3. Steroid called major breakthrough for COVID-19 patients may be harmful for…

Hospitals report steroid shortage | Mayo to end furloughs months early | US aims to 'take flu off the table,' buys 7M vaccine doses | Bayer to pay $10B+ to settle Roundup suits | WHO outlines COVID-19 vaccine distribution plan

June 25, 2020 BHR Newsletter Virtual Events • Webinars • Recent Whitepapers • Podcasts 1. Cheap steroid in shortage after being posited as potential COVID-19 treatment Full story 2. WHO outlines COVID-19 vaccine distribution plan Full story 3. US aims to 'take flu off…

CVS to sell employers COVID-19 testing program | 6 pharma, devicemaker bankruptcies | J&J talc verdict cut to $2B | FDA urged to boost safety warning on diabetes med | Nev. pharmacy board staff get 50% retirement match

June 24, 2020 BHR Newsletter Virtual Events • Webinars • Recent Whitepapers • Podcasts 1. White House to end funding of 13 testing sites; COVID-19 hospitalizations jump in 7 states — 5 updates Full story 2. FDA urged to increase safety warnings on common…

Shareholders sue Walmart over opioid distribution | Average pharmacist salary by state | Walgreens resumes immunization services | Texas Children's admits adult patients amid COVID-19 surge

June 23, 2020 BHR Newsletter Virtual Events • Webinars • Recent Whitepapers • Podcasts 1. Walmart sued by shareholders for opioid distribution practices Full story 2. Ramping up US drug production: 3 obstacles to consider Full story 3. Average pharmacist salaries, by state Full story…

Generic remdesivir to cost up to $79 | Kaiser joins Civica Rx | Walmart giving CVS, Walgreens stiff healthcare competition | 9 pharmacists charged in $12M fraud scheme

June 22, 2020 BHR Newsletter Virtual Events • Webinars • Recent Whitepapers • Podcasts 1. Walmart giving CVS, Walgreens stiff healthcare competition, analyst says Full story 2. Generic remdesivir to cost up to $79 per dose Full story 3. Michigan Medicine to lay off…

CMS rule aims to promote value-based drug pricing | 10 facts about steroid deemed 'breakthrough' in COVID-19 fight | Ex-pharma rep pleads guilty to $50M drug fraud | WHO drops hydroxychloroquine from COVID-19 trial

June 18, 2020 BHR Newsletter Virtual Events • Webinars • Recent Whitepapers • Podcasts 1. New CMS rule promotes payer drug price negotiations based on clinical outcomes Full story 2. Nearly 90% of Americans worried about drug price hikes amid pandemic Full…